| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea5297b3438e442da1b827b994ebe532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9edb2fc6da51ab5a2e8d4c04f0246f56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba1400ca175528b8b5bbe016ca61e8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b3c81bc92f0f06434ec1a01cd0137ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05e71f73d4bb37afe8350bdb58416028 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 |
| filingDate |
2002-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63c1f92de16ab308f09c85b1b1ff54cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_373ba45ab753a1099ec854b91bd1b326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a03e97b6c05d46cbc0b7edb276c7211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b23062de9239ed0c219e682f26b6a185 |
| publicationDate |
2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03077838-A2 |
| titleOfInvention |
Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens |
| abstract |
This invention relates generally to immune responses to human immunodeficiency virus coat protein gp160 presented in the form of antigenic compositions, nucleic acids encoding human immunodeficiency virus coat proteins, and vaccines. The invention also relates to methods for production of antigenic compositions containing human immunodeficiency virus coat protein, nucleic acids encoding human immunodeficiency virus coat proteins, and human immunodeficiency virus vaccines. The invention comprises gp120 and gp41 subunits of the human immunodeficiency virus coat protein covalently linked through a peptide linker, as well as additional complexes including those comprising the human immunodeficiency virus coat protein and it's natural cellular receptor molecules. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058604-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2423332-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2423333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2873423-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110339355-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110339355-A |
| priorityDate |
2002-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |